Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen J, Wang Y, Yao K. Protection of retinal ganglion cells in glaucoma: current status and future. Exp Eye Res. 2021;205:108506.

Article  CAS  PubMed  Google Scholar 

Wiggs JL, Pasquale LR. Genetics of glaucoma. Hum Mol Genet. 2017;26(R1):R21–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Challa P, Schmidt S, Liu Y, et al. Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis. 2008;14:146.

CAS  PubMed  PubMed Central  Google Scholar 

Rowan S, Jiang S, Korem T, et al. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A. 2017;114(22):E4472–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Ye Z, Li Z. Identification of the potential biological target molecules related to primary open-angle glaucoma. BMC Ophthalmol. 2022;22(1):188.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol. 2008;246(11):1593–601.

Article  PubMed  Google Scholar 

Lin HC, Chien CW, Hu CC, et al. Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study. Ophthalmology. 2010;117(11):2088–95.

Article  PubMed  Google Scholar 

Yadav KS, Rajpurohit R, Sharma S. Glaucoma: current treatment and impact of advanced drug delivery systems. Life Sci. 2019;221:362–76.

Article  CAS  PubMed  Google Scholar 

Ma A, Yu SWY, Wong JKW. Micropulse laser for the treatment of glaucoma: a literature review. Surv Ophthalmol. 2019;64(4):486–97.

Article  PubMed  Google Scholar 

Lim R. The surgical management of glaucoma: a review. Clin Exp Ophthalmol. 2022;50(2):213–31.

Article  PubMed  Google Scholar 

Tezel G. The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res. 2011;93(2):178–86.

Article  CAS  PubMed  Google Scholar 

Tezel G. Immune regulation toward immunomodulation for neuroprotection in glaucoma. Curr Opin Pharmacol. 2013;13(1):23–31.

Article  CAS  PubMed  Google Scholar 

Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol. 2004;15(2):80–4.

Article  PubMed  Google Scholar 

Coleman AL. Glaucoma. Lancet. 1999;354(9192):1803–10.

Article  CAS  PubMed  Google Scholar 

Saccà SC, Gandolfi S, Bagnis A, et al. From DNA damage to functional changes of the trabecular meshwork in aging and glaucoma. Ageing Res Rev. 2016;29:26–41.

Article  PubMed  Google Scholar 

Buffault J, Labbé A, Hamard P, et al. The trabecular meshwork: structure, function and clinical implications. A review of the literature. J Fr Ophtalmol. 2020;43(7):e217–30.

Article  CAS  PubMed  Google Scholar 

Zhang T, Xie X, Lu F. Primary open-angle glaucoma: neuroendocrine-immune disorder? Med Hypotheses. 2014;83(4):514–5.

Article  CAS  PubMed  Google Scholar 

Williams PA, Marsh-Armstrong N, Howell GR. Neuroinflammation in glaucoma: a new opportunity. Exp Eye Res. 2017;157:20–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takiishi T, Fenero CIM, Câmara NOS. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers. 2017;5(4):e1373208.

Article  PubMed  PubMed Central  Google Scholar 

Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124(4):837–48.

Article  CAS  PubMed  Google Scholar 

Chen Y, Zhou J, Wang L. Role and Mechanism of gut microbiota in human disease. Front Cell Infect Microbiol. 2021;11:625913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsiras D, Bezati S, Ventoulis I et al. Gut failure: a review of the pathophysiology and therapeutic potentials in the gut-heart axis. J Clin Med. 2023;12(7):2567.

Peh A, O’donnell JA, Broughton BRS, et al. Gut microbiota and their metabolites in stroke: a double-edged sword. Stroke. 2022;53(5):1788–801.

Article  CAS  PubMed  Google Scholar 

Ahlawat S, Asha Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol. 2021;72(6):636–68.

Article  CAS  PubMed  Google Scholar 

Trøseid M, Andersen G, Broch K, et al. The gut microbiome in coronary artery disease and heart failure: current knowledge and future directions. EBioMedicine. 2020;52:102649.

Article  PubMed  PubMed Central  Google Scholar 

Bubnov R, Golubnitschaja O. Flammer syndrome, disordered eating and microbiome: interrelations, complexity of risks and individual outcomes. In: Golubnitschaja O, editor. Flammer syndrome: from phenotype to associated pathologies, prediction, prevention and personalisation. Cham: Springer International Publishing; 2019. p. 317–30.

Chapter  Google Scholar 

Floyd JL, Grant MB. The gut-eye axis: lessons learned from murine models. Ophthalmol Ther. 2020;9(3):499–513.

Article  PubMed  PubMed Central  Google Scholar 

Rowan S, Jiang S, Korem T, et al. Involvement of a gut–retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci. 2017;114(22):E4472–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yempén REA, Venzel R, Campos MCP, et al. Gut microbiota: a potential therapeutic target for management of diabetic retinopathy? Life Sci. 2021;286:120060.

Article  Google Scholar 

Napolitano P, Filippelli M, Davinelli S, et al. Influence of gut microbiota on eye diseases: an overview. Ann Med. 2021;53(1):750–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mcpherson ZE, Sorensen HT, Horvath-Puho E, et al. Irritable bowel syndrome and risk of glaucoma: an analysis of two independent population-based cohort studies. United Eur Gastroenterol J. 2021;9(9):1057–65.

Article  Google Scholar 

Gong H, Zhang S, Li Q, et al. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma. Exp Eye Res. 2020;191:107921.

Article  CAS  PubMed  Google Scholar 

Gong H, Zeng R, Li Q, et al. The profile of gut microbiota and central carbon-related metabolites in primary angle-closure glaucoma patients. Int Ophthalmol. 2022;42(6):1927–38.

Article  PubMed  Google Scholar 

Golubnitschaja O, Bubnov R. Microbiome in Lean individuals: phenotype-specific risks and outcomes. In: Boyko N, Golubnitschaja O, editors. Microbiome in 3P medicine strategies: the first exploitation guide. Cham: Springer International Publishing; 2023. p. 87–99.

Chapter  Google Scholar 

Bubnov R, Spivak M. Pathophysiology-based individualized use of probiotics and prebiotics for metabolic syndrome: implementing predictive, preventive, and personalized medical approach. In: Boyko N, Golubnitschaja O, editors. Microbiome in 3P medicine strategies: the first exploitation guide. Cham: Springer International Publishing; 2023. p. 133–96.

Chapter  Google Scholar 

Reid G, Abrahamsson T, Bailey M, et al. How do probiotics and prebiotics function at distant sites? Benef Microbes. 2017;8(4):521–33.

Article  CAS  PubMed  Google Scholar 

Chen Q, Zhao B, Wang MY, et al. Associations between the red blood cell distribution width and primary angle-closure glaucoma: a potential for disease prediction. EPMA J. 2019;10(2):185–93.

Article  PubMed  PubMed Central  Google Scholar 

Li S, Qiu Y, Yu J, et al. Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure glaucoma: potential biomarkers for 3P medical approaches. EPMA J. 2021;12(4):659–75.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Q, Wang N, Rui Y, et al. New insight of metabolomics in ocular diseases in the context of 3P medicine. EPMA J. 2023;14(1):53–71.

Article  PubMed  PubMed Central